Why is allometric scaling used when predicting pharmacokinetics across body sizes?

• A. To ignore body size and only consider drug properties.
• B. To predict changes in clearance and volume of distribution with body size using exponents.
• C. To adjust dosing solely based on age.
• D. To determine the drug's therapeutic index.

Answer: (B)

Allometric scaling uses how physiological parameters change with body size to predict pharmacokinetics across different body weights. In PK, clearance and volume of distribution don’t scale linearly with mass; metabolic capacity and organ sizes grow in a non-linear way. By applying body-weight exponents, we can estimate how these parameters shift when moving from one size to another. For many drugs, clearance tends to scale with weight raised to about 0.75, while volume of distribution scales with weight raised to about 1.0. This means you can predict new PK values by multiplying the known values by (weight_new / weight_old) raised to the appropriate exponent. Thus, allometric scaling provides a principled way to adjust predictions of how fast a drug is cleared and how widely it distributes across different body sizes. It isn’t about ignoring body size or focusing only on age or therapeutic index.